Core Points - The stock price of Puris has increased by 5.15% to 47.99 CNY per share, with a total market capitalization of 3.791 billion CNY, and a cumulative increase of 6.04% over the past four days [1] - Puris (Shanghai) Pharmaceutical Technology Development Co., Ltd. was established on February 22, 2013, and went public on May 17, 2022, focusing on technology development, transfer, consultation, and services in the pharmaceutical sector, with 100% of its revenue coming from services [1] Fund Holdings - According to data, one fund under Nuoan Fund holds Puris as a significant position, with Nuoan Jingxin Mixed Fund (002145) owning 50,300 shares, accounting for 5.29% of the fund's net value, making it the fourth-largest holding [2] - The fund has generated a floating profit of approximately 118,200 CNY today and 130,800 CNY during the four-day increase [2] - Nuoan Jingxin Mixed Fund was established on December 8, 2015, with a current scale of 45.606 million CNY, achieving a year-to-date return of 57.06% and a one-year return of 57.19% [2]
普蕊斯股价涨5.15%，诺安基金旗下1只基金重仓，持有5.03万股浮盈赚取11.82万元